What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.

They’re tapping into the potential of Ozempic. Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can treat substance abuse. Ozempic — which mimics the body’s naturally occurring GLP-1 hormone to make people feel full and eat less — treats diabetes and can spur weight loss.